🔎 Trials Near Me

Home › Ovarian Epithelial Carcinoma › Montana

Ovarian Epithelial Carcinoma clinical trials in Montana

3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Montana.

Cities in Montana

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer

  • Research Site, Billings
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07851025

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, Billings
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • St. Vincent Gynecologic Oncology, Billings
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.